Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusers

U. Tirelli, E. Vaccher, A. Carbone, P. De Paoli, G. Santini, S. Monfardini

Research output: Contribution to journalArticle

Abstract

To evaluate the role of heterosexual contact as opposed to the sharing of contaminated needles for HTLV-III transmission among intravenous (IV) drug abusers, between May and October 1985 we fully evaluated 30 couples in which both persons were IV drug abusers and 21 couples in which only one was an IV drug abuser (19 male and two female) while each had a heterosexual partner not belonging to known groups at risk for AIDS and a stable, long-term heterosexual relationship (>1 year; median duration, 2.5 years). All IV drug abusers admitted frequent sharing of syringes. Sexual behavior, evaluated through a questionnaire, was similar in both groups. In particular, the frequency of sexual contacts was low (less than one sexual contact per week). The control group consisted of 20 age-matched couples evaluated in a concomitant study on sexual behavior prior to and after the diagnosis of malignant disease in one of the partners (two or more sexual contacts per week). Of 30 couples composed of two IV drug abusers, seven couples were concomitantly seropositive and 18 were concomitantly seronegative. The remaining five couples had discordant serological test findings. On the other hand, of 21 couples composed of an IV drug abuser and a non-IV drug abuser, antibodies to HTLV-III were detected in only one heterosexual partner of the-12 seropositive IV drug abusers and in none of the heterosexual partners of the remaining nine seronegative IV drug abusers. Therefore, among the overall 24 couples in which one or both partners were seropositive, concordance in HTLV-III seropositivity was present in seven (58%) of 12 couples composed of IV drug abusers and in only one (8%) of 12 couples composed of an IV drug abuser and a non-IV drug abuser. Taking into consideration the general practice of sharing of syringes among our IV drug abuser population, we can conclude that the sharing of contaminated needles plays a major role in the transmission of HTLV-III infection among IV drug abusers.

Original languageEnglish
Pages (from-to)2289
Number of pages1
JournalJournal of the American Medical Association
Volume255
Issue number17
DOIs
Publication statusPublished - 1986

Fingerprint

Heterosexuality
Drug Users
HIV
Needle Sharing
Sexual Behavior
HIV Seropositivity
HIV Antibodies
Serologic Tests
General Practice
HIV Infections
Acquired Immunodeficiency Syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusers. / Tirelli, U.; Vaccher, E.; Carbone, A.; De Paoli, P.; Santini, G.; Monfardini, S.

In: Journal of the American Medical Association, Vol. 255, No. 17, 1986, p. 2289.

Research output: Contribution to journalArticle

@article{d0c0456ce1104a6c9865fc4a565e46e1,
title = "Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusers",
abstract = "To evaluate the role of heterosexual contact as opposed to the sharing of contaminated needles for HTLV-III transmission among intravenous (IV) drug abusers, between May and October 1985 we fully evaluated 30 couples in which both persons were IV drug abusers and 21 couples in which only one was an IV drug abuser (19 male and two female) while each had a heterosexual partner not belonging to known groups at risk for AIDS and a stable, long-term heterosexual relationship (>1 year; median duration, 2.5 years). All IV drug abusers admitted frequent sharing of syringes. Sexual behavior, evaluated through a questionnaire, was similar in both groups. In particular, the frequency of sexual contacts was low (less than one sexual contact per week). The control group consisted of 20 age-matched couples evaluated in a concomitant study on sexual behavior prior to and after the diagnosis of malignant disease in one of the partners (two or more sexual contacts per week). Of 30 couples composed of two IV drug abusers, seven couples were concomitantly seropositive and 18 were concomitantly seronegative. The remaining five couples had discordant serological test findings. On the other hand, of 21 couples composed of an IV drug abuser and a non-IV drug abuser, antibodies to HTLV-III were detected in only one heterosexual partner of the-12 seropositive IV drug abusers and in none of the heterosexual partners of the remaining nine seronegative IV drug abusers. Therefore, among the overall 24 couples in which one or both partners were seropositive, concordance in HTLV-III seropositivity was present in seven (58{\%}) of 12 couples composed of IV drug abusers and in only one (8{\%}) of 12 couples composed of an IV drug abuser and a non-IV drug abuser. Taking into consideration the general practice of sharing of syringes among our IV drug abuser population, we can conclude that the sharing of contaminated needles plays a major role in the transmission of HTLV-III infection among IV drug abusers.",
author = "U. Tirelli and E. Vaccher and A. Carbone and {De Paoli}, P. and G. Santini and S. Monfardini",
year = "1986",
doi = "10.1001/jama.255.17.2289",
language = "English",
volume = "255",
pages = "2289",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "17",

}

TY - JOUR

T1 - Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusers

AU - Tirelli, U.

AU - Vaccher, E.

AU - Carbone, A.

AU - De Paoli, P.

AU - Santini, G.

AU - Monfardini, S.

PY - 1986

Y1 - 1986

N2 - To evaluate the role of heterosexual contact as opposed to the sharing of contaminated needles for HTLV-III transmission among intravenous (IV) drug abusers, between May and October 1985 we fully evaluated 30 couples in which both persons were IV drug abusers and 21 couples in which only one was an IV drug abuser (19 male and two female) while each had a heterosexual partner not belonging to known groups at risk for AIDS and a stable, long-term heterosexual relationship (>1 year; median duration, 2.5 years). All IV drug abusers admitted frequent sharing of syringes. Sexual behavior, evaluated through a questionnaire, was similar in both groups. In particular, the frequency of sexual contacts was low (less than one sexual contact per week). The control group consisted of 20 age-matched couples evaluated in a concomitant study on sexual behavior prior to and after the diagnosis of malignant disease in one of the partners (two or more sexual contacts per week). Of 30 couples composed of two IV drug abusers, seven couples were concomitantly seropositive and 18 were concomitantly seronegative. The remaining five couples had discordant serological test findings. On the other hand, of 21 couples composed of an IV drug abuser and a non-IV drug abuser, antibodies to HTLV-III were detected in only one heterosexual partner of the-12 seropositive IV drug abusers and in none of the heterosexual partners of the remaining nine seronegative IV drug abusers. Therefore, among the overall 24 couples in which one or both partners were seropositive, concordance in HTLV-III seropositivity was present in seven (58%) of 12 couples composed of IV drug abusers and in only one (8%) of 12 couples composed of an IV drug abuser and a non-IV drug abuser. Taking into consideration the general practice of sharing of syringes among our IV drug abuser population, we can conclude that the sharing of contaminated needles plays a major role in the transmission of HTLV-III infection among IV drug abusers.

AB - To evaluate the role of heterosexual contact as opposed to the sharing of contaminated needles for HTLV-III transmission among intravenous (IV) drug abusers, between May and October 1985 we fully evaluated 30 couples in which both persons were IV drug abusers and 21 couples in which only one was an IV drug abuser (19 male and two female) while each had a heterosexual partner not belonging to known groups at risk for AIDS and a stable, long-term heterosexual relationship (>1 year; median duration, 2.5 years). All IV drug abusers admitted frequent sharing of syringes. Sexual behavior, evaluated through a questionnaire, was similar in both groups. In particular, the frequency of sexual contacts was low (less than one sexual contact per week). The control group consisted of 20 age-matched couples evaluated in a concomitant study on sexual behavior prior to and after the diagnosis of malignant disease in one of the partners (two or more sexual contacts per week). Of 30 couples composed of two IV drug abusers, seven couples were concomitantly seropositive and 18 were concomitantly seronegative. The remaining five couples had discordant serological test findings. On the other hand, of 21 couples composed of an IV drug abuser and a non-IV drug abuser, antibodies to HTLV-III were detected in only one heterosexual partner of the-12 seropositive IV drug abusers and in none of the heterosexual partners of the remaining nine seronegative IV drug abusers. Therefore, among the overall 24 couples in which one or both partners were seropositive, concordance in HTLV-III seropositivity was present in seven (58%) of 12 couples composed of IV drug abusers and in only one (8%) of 12 couples composed of an IV drug abuser and a non-IV drug abuser. Taking into consideration the general practice of sharing of syringes among our IV drug abuser population, we can conclude that the sharing of contaminated needles plays a major role in the transmission of HTLV-III infection among IV drug abusers.

UR - http://www.scopus.com/inward/record.url?scp=0022574615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022574615&partnerID=8YFLogxK

U2 - 10.1001/jama.255.17.2289

DO - 10.1001/jama.255.17.2289

M3 - Article

VL - 255

SP - 2289

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 17

ER -